Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy

Diffuse large B‐cell lymphoma (DLBCL), which is the most prevalent disease subtype of non‐Hodgkin lymphoma, is highly heterogeneous in terms of cytogenetic and molecular features. This study retrospectively investigated the clinical impact of G‐banding‐defined chromosomal abnormality on treatment ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Yoshimi, Tsukamoto, Taku, Kawata, Eri, Uoshima, Nobuhiko, Uchiyama, Hitoji, Yokota, Isao, Maegawa, Saori, Takimoto, Tomoko, Tanba, Kazuna, Matsumura‐Kimoto, Yayoi, Kuwahara‐Ota, Saeko, Fujibayashi, Yuto, Yamamoto‐Sugitani, Mio, Chinen, Yoshiaki, Shimura, Yuji, Horiike, Shigeo, Taniwaki, Masafumi, Kobayashi, Tsutomu, Kuroda, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852349/
https://www.ncbi.nlm.nih.gov/pubmed/29473332
http://dx.doi.org/10.1002/cam4.1342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852349/
https://www.ncbi.nlm.nih.gov/pubmed/29473332
http://dx.doi.org/10.1002/cam4.1342

Ejemplares similares